Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Why Researchers Study Retatrutide Researchers study Retatrutide because it provides a model for exploring how coordinated signaling across GIPR, GLP-1R, and GCGR may influence metabolic pathway research
placebo (1:1:1:1) for the treatment of obesity
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 trial data: Route : Once-weekly subcutaneous injection Dose range studied : 0.5 mg to 12 mg weekly Optimal dose : 12 mg weekly showed maximum efficacy in Phase 2 Titration : Gradual dose escalation over several weeks to manage GI tolerability Tirzepatide Dosing# Established FDA-approved dosing: Route : Once-weekly subcutaneous injection Starting dose : 2.5 mg weekly for 4 weeks Maintenance range : 5 mg, 10 mg, or 15 mg weekly Titration : 2.5 mg increments every 4 weeks to target dose Available formulations : Prefilled pens (Mounjaro/Zepbound) Tirzepatide's established titration protocol and prefilled pen delivery system offer practical advantages in clinical use
Injectable forms are clearly regulated as compounded medications
Heres a closer look at how Pep supports GLP-1 therapy
US$ 27.51
US$ 25.10
US$ 27.00
US$ 29.21
US$ 20.03
US$ 29.43
